Free Trial

Talis Biomedical (TLIS) Short Interest Ratio & Short Volume

Talis Biomedical logo
$1.72
0.00 (0.00%)
(As of 11/1/2024 ET)

Talis Biomedical Short Interest Data

Talis Biomedical (TLIS) has a short interest of 20,100 shares, representing 1.20% of the float (the number of shares available for trading by the public). This marks a 11.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 4,755 shares to cover all short positions.

Current Short Interest
20,100 shares
Previous Short Interest
18,000 shares
Change Vs. Previous Month
+11.67%
Dollar Volume Sold Short
$88,038.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
August 31, 2024
Outstanding Shares
1,820,000 shares
Float Size
1,670,000 shares
Short Percent of Float
1.20%
Today's Trading Volume
32 shares
Average Trading Volume
4,755 shares
Today's Volume Vs. Average
1%
Short Selling Talis Biomedical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Talis Biomedical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TLIS Short Interest Over Time

TLIS Days to Cover Over Time

TLIS Percentage of Float Shorted Over Time

Talis Biomedical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202420,100 shares $88,038.00 +11.7%1.2%0.7 $4.38
8/15/202418,000 shares $74,520.00 -15.5%1.1%1 $4.14
7/31/202421,300 shares $184,777.50 +52.1%1.3%1.5 $8.68
7/15/202414,000 shares $118,160.00 -4.8%0.8%2.1 $8.44
6/30/202414,700 shares $127,328.46 +9.7%0.9%2 $8.66
6/15/202413,400 shares $119,394.00 No Change0.8%1.8 $8.91
5/31/202413,400 shares $123,280.00 +5.5%0.8%1.8 $9.20
5/15/202412,700 shares $113,665.00 -5.2%0.8%1.6 $8.95
4/30/202413,400 shares $115,508.00 +8.9%0.8%1.5 $8.62
4/15/202412,300 shares $104,427.00 -7.5%0.7%1.4 $8.49
3/31/202413,300 shares $116,375.00 -4.3%0.8%1.5 $8.75
3/15/202413,900 shares $126,490.00 +6.9%0.8%1.5 $9.10
2/29/202413,000 shares $104,520.00 -8.5%0.8%1.3 $8.04
2/15/202414,200 shares $121,268.00 -22.4%0.9%1.3 $8.54
1/31/202418,300 shares $142,008.00 +7.0%1.1%1.1 $7.76
1/15/202417,100 shares $139,365.00 +18.8%1.0%1 $8.15
12/31/202314,400 shares $107,280.00 -37.7%0.9%0.9 $7.45
12/15/202323,100 shares $185,955.00 +1.8%1.4%1.4 $8.05
11/30/202322,700 shares $173,655.00 +33.5%1.4%1.5 $7.65
11/15/202317,000 shares $125,120.00 -0.6%1.0%1.2 $7.36
10/31/202317,100 shares $81,738.00 +19.6%1.0%2.5 $4.78
10/15/202314,300 shares $75,791.43 +24.4%0.9%2.2 $5.30
9/30/202311,500 shares $66,355.00 -25.8%0.7%1.1 $5.77
9/15/202315,500 shares $95,945.00 +10.7%0.9%1.2 $6.19
8/31/202314,000 shares $86,800.00 -21.8%0.8%1.1 $6.20
8/15/202317,900 shares $127,448.00 -20.8%1.1%1.2 $7.12
7/31/202322,600 shares $169,048.00 -5.8%1.4%1.5 $7.48
7/15/202324,000 shares $189,280.80 +56.9%1.5%1.7 $7.89
6/30/202315,300 shares $110,160.00 -94.1%0.9%1.3 $7.20
6/15/2023258,600 shares $116,628.60 +42.4%1.1%2.1 $0.45
5/31/2023181,600 shares $89,056.64 -27.0%0.8%1.6 $0.49
5/15/2023248,600 shares $111,870.00 -25.2%1.0%2.9 $0.45
4/30/2023332,400 shares $162,876.00 +21.4%1.4%3.9 $0.49
4/15/2023273,900 shares $127,116.99 -7.6%1.1%3 $0.46
3/31/2023296,300 shares $145,187.00 +6.0%1.2%3.4 $0.49
3/15/2023279,500 shares $156,799.50 +10.7%1.2%2.4 $0.56
2/28/2023252,400 shares $146,392.00 -10.6%1.1%2.2 $0.58
2/15/2023282,200 shares $172,508.86 +25.3%1.2%2.5 $0.61
1/31/2023225,300 shares $141,510.70 -4.1%0.9%2.1 $0.63
1/15/2023234,800 shares $135,362.20 -9.7%1.0%2.1 $0.58
Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).
12/30/2022260,000 shares $115,882.00 +10.5%1.1%2.1 $0.45
12/15/2022235,300 shares $128,709.10 +3.4%1.0%2.2 $0.55
11/30/2022227,600 shares $124,884.12 -1.0%1.0%2 $0.55
11/15/2022230,000 shares $115,046.00 -28.3%1.0%1.8 $0.50
10/31/2022320,900 shares $213,430.59 +13.0%1.3%1.5 $0.67
10/15/2022283,900 shares $196,118.12 +1.1%1.2%1.3 $0.69
9/30/2022280,800 shares $191,393.28 +14.3%1.2%1.4 $0.68
9/15/2022245,600 shares $219,222.56 -0.4%1.0%1.1 $0.89
8/31/2022246,500 shares $221,850.00 -19.3%1.0%1.1 $0.90
8/15/2022305,400 shares $264,262.62 +14.9%1.3%1.3 $0.87
7/31/2022265,900 shares $210,061.00 -10.2%1.1%1.6 $0.79
7/15/2022296,200 shares $258,878.80 -13.8%1.2%1.7 $0.87
6/30/2022343,700 shares $279,084.40 -57.3%1.4%1.9 $0.81
6/15/2022804,300 shares $770,438.97 +0.7%3.3%4.4 $0.96
5/31/2022798,500 shares $838,425.00 +11.9%3.3%4.3 $1.05
5/15/2022713,300 shares $699,034.00 +1.2%3.0%4.2 $0.98
4/30/2022705,100 shares $740,355.00 +27.5%2.9%4.7 $1.05
4/15/2022553,000 shares $707,840.00 +0.6%2.3%4 $1.28
3/31/2022549,700 shares $775,077.00 +9.0%2.3%4 $1.41
3/15/2022504,300 shares $852,267.00 -0.9%2.1%3.4 $1.69
2/28/2022508,900 shares $1.06 million +8.8%2.1%3.8 $2.09
2/15/2022467,900 shares $1.02 million -10.6%2.0%3 $2.18
1/31/2022523,300 shares $1.54 million -4.3%2.3%2.7 $2.95
1/15/2022546,900 shares $1.78 million -28.5%2.5%2.9 $3.26
12/31/2021764,700 shares $3.07 million -16.9%3.4%3.9 $4.01
12/15/2021919,700 shares $3.72 million +33.1%4.1%4.7 $4.04
11/30/2021691,200 shares $3.23 million -63.8%3.1%3.5 $4.68
11/15/20211,910,000 shares $11.08 million +11.1%8.6%9.9 $5.80
10/29/20211,720,000 shares $9.20 million +11.7%7.9%7.8 $5.35
10/15/20211,540,000 shares $8.81 million +10.8%7.1%6.6 $5.72
9/30/20211,390,000 shares $8.69 million +8.6%6.4%4.2 $6.25
9/15/20211,280,000 shares $9.60 million -4.5%5.9%3.7 $7.50
8/31/20211,340,000 shares $10.80 million -19.3%6.2%3.6 $8.06
8/13/20211,660,000 shares $12.85 million No Change7.6%4.6 $7.74

TLIS Short Interest - Frequently Asked Questions

What is Talis Biomedical's current short interest?

Short interest is the volume of Talis Biomedical shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 20,100 shares of TLIS short. 1.20% of Talis Biomedical's shares are currently sold short. Learn More on Talis Biomedical's current short interest.

What is a good short interest ratio for Talis Biomedical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLIS shares currently have a short interest ratio of 1.0. Learn More on Talis Biomedical's short interest ratio.

What is a good short interest percentage for Talis Biomedical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.20% of Talis Biomedical's floating shares are currently sold short.

Is Talis Biomedical's short interest increasing or decreasing?

Talis Biomedical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 20,100 shares, an increase of 11.7% from the previous total of 18,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Talis Biomedical's float size?

Talis Biomedical currently has issued a total of 1,820,000 shares. Some of Talis Biomedical's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Talis Biomedical currently has a public float of 1,670,000 shares.

How does Talis Biomedical's short interest compare to its competitors?

1.20% of Talis Biomedical's shares are currently sold short. Here is how the short interest of companies compare to Talis Biomedical: Cue Health Inc. (0.69%), Precipio, Inc. (0.38%), Telesis Bio, Inc. (5.67%), Spectaire Holdings Inc. (3.50%), ThermoGenesis Holdings, Inc. (1.94%), Lucid Diagnostics Inc. (5.73%), Biodesix, Inc. (0.29%), Sera Prognostics, Inc. (5.67%), QuidelOrtho Co. (6.29%), Quest Diagnostics Incorporated (2.10%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.

What does it mean to sell short Talis Biomedical stock?

Short selling TLIS is an investing strategy that aims to generate trading profit from Talis Biomedical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Talis Biomedical?

A short squeeze for Talis Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TLIS, which in turn drives the price of the stock up even further.

How often is Talis Biomedical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLIS, twice per month. The most recent reporting period available is August, 31 2024.




This page (NASDAQ:TLIS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners